Treatment innovations in cardiology: highlights from ESC Congress 2024
Hospital Pharmacy Europe
SEPTEMBER 24, 2024
Indeed, vutrisiran – a new drug for the treatment of amyloidosis – has been found to be effective in reducing mortality, cardiovascular events and markers of disease progression. These documents, based on the most up-to-date evidence, are invaluable reference tools in the clinical practice of the cardiology community around the world.
Let's personalize your content